Dr. Tripathy on the Development of Palbociclib in Breast Cancer

Article

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the development of palbociclib (Ibrance) in breast cancer.

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the development of palbociclib (Ibrance) in breast cancer.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Image of a woman with blond hair wearing a headset and a hospital badge over a blouse in front of a watercolor Oncology Nursing News background
Related Content
Image of a woman with dark brown hair wearing a blazer in front of an Oncology Nursing News bakcground

Imlunestrant vs Elacestrant: MOA and Clinical Trial Differences

Komal Jhaveri, MD, FACP
October 11th 2025
Article
Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer
October 11th 2025
Podcast
Graphic resembling a seal of approval that says "FDA Approved"

FDA Approves Imlunestrant in ESR1+ HR+, HER2- Metastatic Breast Cancer

Bridget Hoyt
October 11th 2025
Article
The Vitals

Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

Lindsay Fischer
October 11th 2025
Podcast
Graphic depicting a nurse with a cell strucutre behind. Graphic by Gwendolyn Salas, MJH Life Sciences, with AI

Structure to Safety: A Nurse's Guide to Safe ADC Care

Ellen Rice Tichich, MFA, MSN, RN, NPD-BC
October 11th 2025
Article
Kelsey Martin, APRN, AG-ACNP-BC, AOCNP

A Nurse’s Overview of First-Line Treatment for HR+ Metastatic Breast Cancer

Bridget Hoyt
October 11th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.